CeNeS hurries to grow

Growing companies through in-licensing marketed products has not always been successful: such products are often pharmaceutical company cast-offs at the end of their life cycle. But CeNeS Pharmaceuticals plc, which just acquired three pain killing products from Glaxo Wellcome plc, believes having a pharmaceuticals division is a vital component

Read the full 492 word article

How to gain access

Continue reading with a
two-week free trial.